USD 0.49
(-13.84%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 1.17 Million USD | 6.03% |
2021 | 1.11 Million USD | -31.67% |
2020 | 1.62 Million USD | -50.65% |
2019 | 3.29 Million USD | 285.83% |
2018 | 854 Thousand USD | -10.67% |
2017 | 956 Thousand USD | -55.62% |
2016 | 2.15 Million USD | 362.23% |
2015 | 466 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 FY | - USD | -100.0% |
2023 Q3 | 5000.00 USD | -54.55% |
2023 Q4 | - USD | -100.0% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | 11 Thousand USD | 0.0% |
2022 Q2 | 901 Thousand USD | -13.78% |
2022 Q4 | 1.17 Million USD | 34.78% |
2022 FY | 1.17 Million USD | 6.03% |
2022 Q1 | 1.04 Million USD | -5.94% |
2022 Q3 | 874 Thousand USD | -3.0% |
2021 Q3 | 1.55 Million USD | 14.16% |
2021 Q4 | 1.11 Million USD | -28.6% |
2021 Q2 | 1.36 Million USD | -3.95% |
2021 Q1 | 1.41 Million USD | -12.73% |
2021 FY | 1.11 Million USD | -31.67% |
2020 Q4 | 1.62 Million USD | -17.96% |
2020 FY | 1.62 Million USD | -50.65% |
2020 Q1 | 3.09 Million USD | -5.95% |
2020 Q3 | 1.98 Million USD | -24.9% |
2020 Q2 | 2.63 Million USD | -14.84% |
2019 Q3 | 2.98 Million USD | 4.78% |
2019 Q2 | 2.84 Million USD | 18.35% |
2019 Q1 | 2.4 Million USD | 181.38% |
2019 FY | 3.29 Million USD | 285.83% |
2019 Q4 | 3.29 Million USD | 10.57% |
2018 Q4 | 854 Thousand USD | -0.23% |
2018 FY | 854 Thousand USD | -10.67% |
2018 Q3 | 856 Thousand USD | 29.11% |
2018 Q2 | 663 Thousand USD | -0.45% |
2018 Q1 | 666 Thousand USD | -30.33% |
2017 Q1 | 1.85 Million USD | -14.02% |
2017 Q3 | 969 Thousand USD | -38.67% |
2017 Q4 | 956 Thousand USD | -1.34% |
2017 Q2 | 1.58 Million USD | -14.69% |
2017 FY | 956 Thousand USD | -55.62% |
2016 Q2 | 1.32 Million USD | 45.93% |
2016 Q4 | 2.15 Million USD | 55.64% |
2016 Q3 | 1.38 Million USD | 4.22% |
2016 FY | 2.15 Million USD | 362.23% |
2016 Q1 | 910 Thousand USD | 95.28% |
2015 Q4 | 466 Thousand USD | 46599900.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | 466 Thousand USD | 0.0% |
2015 Q3 | 1.00 USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 100.0% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 100.0% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 100.0% |
Cosmos Health Inc. | 4.78 Million USD | 100.0% |
Dynavax Technologies Corporation | 53.29 Million USD | 100.0% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 100.0% |
Pacira BioSciences, Inc. | 104.35 Million USD | 100.0% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
SCYNEXIS, Inc. | - USD | NaN% |
Safety Shot Inc | 1.86 Million USD | 100.0% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 100.0% |
Alpha Teknova, Inc. | 11.59 Million USD | 100.0% |
Bright Green Corporation | - USD | NaN% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 100.0% |
Embecta Corp. | 152.1 Million USD | 100.0% |
PainReform Ltd. | - USD | NaN% |
Journey Medical Corporation | 10.2 Million USD | 100.0% |
Procaps Group, S.A. | 96.83 Million USD | 100.0% |
Theratechnologies Inc. | 6.06 Million USD | 100.0% |
Harrow Health, Inc. | 10.86 Million USD | 100.0% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 100.0% |
Biofrontera Inc. | 10.9 Million USD | 100.0% |
DURECT Corporation | 2.21 Million USD | 100.0% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 100.0% |
Cronos Group Inc. | 30.33 Million USD | 100.0% |
OptiNose, Inc. | 8.05 Million USD | 100.0% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Kala Pharmaceuticals, Inc. | - USD | NaN% |
RedHill Biopharma Ltd. | 5.69 Million USD | 100.0% |
Organogenesis Holdings Inc. | 28.25 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 2.67 Million USD | 100.0% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 100.0% |
Radius Health, Inc. | 278.64 Million USD | 100.0% |
Universe Pharmaceuticals INC | 3.34 Million USD | 100.0% |
ProPhase Labs, Inc. | 3.84 Million USD | 100.0% |
Phibro Animal Health Corporation | 265.91 Million USD | 100.0% |
Procaps Group S.A. | 96.83 Million USD | 100.0% |
Alvotech | 74.43 Million USD | 100.0% |
TherapeuticsMD, Inc. | - USD | NaN% |
Viatris Inc. | 3.46 Billion USD | 100.0% |
Rockwell Medical, Inc. | 5.87 Million USD | 100.0% |
Aytu BioPharma, Inc. | 12.63 Million USD | 100.0% |
SIGA Technologies, Inc. | 64.21 Million USD | 100.0% |
Tilray Brands, Inc. | 252.08 Million USD | 100.0% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 100.0% |
Shineco, Inc. | 1.58 Million USD | 100.0% |
PetIQ, Inc. | 159.3 Million USD | 100.0% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 100.0% |
Incannex Healthcare Limited | -10.01 Million USD | 100.0% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 100.0% |
Alimera Sciences, Inc. | 1.87 Million USD | 100.0% |
Silver Spike Investment Corp. | - USD | NaN% |
Assertio Holdings, Inc. | 37.68 Million USD | 100.0% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | NaN% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | 100.0% |
Clever Leaves Holdings Inc. | 4.48 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 100.0% |
Hempacco Co., Inc. | 2.54 Million USD | 100.0% |
Alvotech | 74.43 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 100.0% |
Lantheus Holdings, Inc. | 64.02 Million USD | 100.0% |
Currenc Group, Inc. | 732.91 Thousand USD | 100.0% |
Kamada Ltd. | 87.74 Million USD | 100.0% |
Indivior PLC | 141.79 Million USD | 100.0% |
Evoke Pharma, Inc. | 481.84 Thousand USD | 100.0% |
Flora Growth Corp. | 8.5 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Evolus, Inc. | 10.99 Million USD | 100.0% |
HUTCHMED (China) Limited | 50.25 Million USD | 100.0% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 100.0% |
Akanda Corp. | 1.28 Million USD | 100.0% |